Alzheimer’s Research UK has announced proposals to create Europe’s first Drug Discovery Institute for neurodegenerative diseases including dementia.
The aim of the multi-million pound Drug Discovery Institute will be to accelerate progress towards effective treatments for Alzheimer’s disease and other dementias.
“The Institute will provide the essential link between fundamental research into neurodegenerative diseases, and patient benefit”.
Alzheimer’s Research UK are inviting active research teams at leading universities and / or research institutes to submit their interest in becoming the host for the Drug Discovery Institute.
Read more: Drug Discovery Institute.